Abstract:Abstract Microsatellite instability (MSI), a functional measure of mismatch repair (MMR) deficiency, and immunohistochemistry testing for MMR proteins are well established technologies traditionally used for Lynch Syndrome screening in colorectal cancer. Recently testing for MMR deficiency, by MSI analysis or MMR protein expression, has expanded from hereditary cancer risk testing to a new role predicting immunotherapeutic response in all solid tumors. With this increase in utility and awareness, mismatch repair deficiency is now relevant in a variety of other cancer tissue types. However, little data is available for the performance of these testing techniques in non-colorectal cancer samples. In this study, we examine performance of methods for detecting MSI and MMR protein expression in endometrial cancer samples. 200 endometrial cancer samples were obtained for testing with MSI by PCR followed by capillary electrophoresis, and immunohistochemistry for MMR protein expression. Instability at 2/5 microsatellite loci was used as criteria for MSI-H designation and loss of immunostaining for one or more MMR protein was considered dMMR. Performance of these analysis methods for identification of MMR protein mutations was measured by comparing results to sequencing of MMR proteins using NGS. MSI by PCR followed by capillary electrophoresis and immunohistochemistry for all four major MMR proteins was successfully performed on all (200/200) samples. 140/200 samples had matched adjacent tissue for reference when performing MSI analysis. MSI and MMR did not exhibit 100% concordance, as expected due to their measurement of different biological effects associated with MMR deficiency. We also describe instances of microsatellite loci exhibiting more subtle shifts than those commonly observed in colorectal cancer, especially at shorter nucleotide repeats, an important consideration for future studies with pan-tumor MSI testing. With the increasing utility of identifying mismatch repair defects in hereditary and immuno-oncology for pan-tumor applications, choosing a testing approach that has the highest sensitivity is key. Our findings suggest that for maximal identification of mismatch repair deficiency, MMR by IHC and MSI by PCR are complementary technologies and should not be considered interchangeable. Consistent with these findings, a number of guideline committees globally have begun recommending co-testing for MMR and MSI. These two cost effective tools can be used together for both a functional and informative approach prior to more costly downstream testing. Citation Format: Samantha R. Lewis, Kathryn Oostdik, Shaun Peterson, Heather Tomlinson. A performance characterization of microsatellite instability and mismatch repair testing methods in endometrial samples [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 4251.

Construction of a Model Used for the Mismatch Repair Functional Analysis in Vitro and Being Used in the Human Colorectal Cancer Cell Line and Tumor Tissue

Construction of Heteroduplex DNA Andin Vitro Model for Functional Analysis of Mismatch Repair

DNA Mismatch Repair Preferentially Protects Genes from Mutation.

Immunohistochemistry and Microsatellite Instability Analysis in Molecular Subtyping of Colorectal Carcinoma Based on Mismatch Repair Competency.

A Novel and Reliable Method to Detect Microsatellite Instability in Colorectal Cancer by Next-Generation Sequencing.

Application of Capillary Electrophoresis in Detecting Mutation of Hmlh1 Gene in Colorectal Cancer

[Mutation of Human Mismatch Repair Genes in Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Families].

Mouse models of DNA mismatch repair in cancer research

Analysis of Human MutS Homolog 2 Missense Mutations in Patients with Colorectal Cancer

Association Between Mismatch Repair Gene and Irinotecan-Based Chemotherapy in Metastatic Colon Cancer

The Relationship Between Mismatch Repair (MMR) Proteins Status and the Response to Conventional Neoadjuvant Therapy in Colorectal Cancer (CRC).

Abstract 4251: A performance characterization of microsatellite instability and mismatch repair testing methods in endometrial samples

[Mismatch Pair Defective Phenotype in Hereditary Nonpolyposis Colorectal Cancer in the Chinese].

Analysis of clinical characteristics of mismatch repair status in colorectal cancer: a multicenter retrospective study

Immunoexpression of Mismatch Repair Proteins in a Cohort of Colorectal Cancer Patients

Mutation Detection of Mismatch Repair Genes in Hereditary Nonpolyposis Colorectal Cancer by Denaturing High-Performance Liquid Chromatography

Microsatellite instability in mismatch repair proficient colorectal cancer: clinical features and underlying molecular mechanisms

Rapid identification of somatic mutations in colorectal and breast cancer tissues using mismatch repair detection (MRD)

The Relationship Between DNA Mismatch Repair Status and Clinicopathologic Characteristics in Colon Cancer

Histomorphological and Molecular Genetic Characterization of Different Intratumoral Regions and Matched Metastatic Lymph Nodes of Colorectal Cancer with Heterogenous Mismatch Repair Protein Expression

Enhanced Commendable Sensitivity and Specificity for MSI in Colorectal Cancer by a New PCR-HRM Based 8-Loci MSI Assay